Lubner David Charles
Director at ACLX; SVP and CFO at TETRAPHASE PHARMACEUTICALS INC
- Sold, on record
- $3M
- Dollars the filings state
- Form 4 sales
- 9
- Latest Jan 20, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- ACLXArcellx, Inc.Director
- TETRAPHASE PHARMACEUTICALS INCSVP and CFO
Sales by reason
Form 4 sales per year, every sale on record.
Sales by company
- TETRAPHASE PHARMACEUTICALS INC81,974 shares
- ACLX6,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale TETRAPHASE PHARMACEUTICALS INCPlan not statedMar 6, 2014 2014
Sold 4,510 shares at $13.65 ($62k)
Lubner David Charles, SVP and CFO
Sold 4.7% of holdings ($1.3M position)91,993 shares leftFiling
- 2 Form 4 sale TETRAPHASE PHARMACEUTICALS INCUnusualJun 17, 2014 +103 days
Sold 13,530 shares at $12.51 ($169k)
Lubner David Charles, SVP and CFO
Sold 14.7% of holdings ($1.2M position)78,463 shares left3x usual sizeFiling
- 3 Form 4 sale TETRAPHASE PHARMACEUTICALS INCPlan not statedMay 14, 2015 +331 days
Sold 15,000 shares at $39.28 ($589k)
Lubner David Charles, SVP and CFO
Sold 15.9% of holdings ($3.7M position)79,270 shares left2.1x usual sizeFiling
- 4 Form 4 sale TETRAPHASE PHARMACEUTICALS INCPlan not statedJun 15, 2015 +32 days
Sold 17,500 shares at $41.45 ($725k)
Lubner David Charles, SVP and CFO
Sold 20.2% of holdings ($3.6M position)69,270 shares left1.8x usual sizeFiling
- 5 Form 4 sale TETRAPHASE PHARMACEUTICALS INCPlan not statedJul 14, 2015 +29 days
Sold 7,500 shares at $48.92 ($367k)
Lubner David Charles, SVP and CFO
Sold 9.8% of holdings ($3.8M position)69,270 shares left0.6x usual sizeFiling
- 6 Form 4 sale TETRAPHASE PHARMACEUTICALS INCPlan not statedAug 14, 2015 +31 days
Sold 9,500 shares at $42.92 ($408k)
Lubner David Charles, SVP and CFO
Sold 12.1% of holdings ($3.4M position)69,270 shares left1x usual sizeFiling
- 7 Form 4 sale ACLXRoutineJan 20, 2026 +3812 days
Sold 6,000 shares at $75.00 ($450k)
Lubner David Charles, Director
10b5-1 planSold 21.7% of holdings ($2.1M position)21,659 shares leftFirst sale on recordFollows a Form 144Filing
- 8 Form 144 notice ACLXNoticeJan 20, 2026 same day
Filed to sell 15,000 shares ($1M)
Lubner David Charles, Director
10b5-1 planFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | Jan 20, 2026 | ACLX | Director | Form 144 notice | 15,000 | $1M | Notice | SEC | |
| Jan 20, 2026 | Jan 20, 2026 | ACLX | Director | Form 4 sale | 6,000 | $450k | 21.7% | Routine | SEC |
| Aug 14, 2015 | Aug 17, 2015 | TETRAPHASE PHARMACEUTICALS INC | SVP and CFO | Form 4 sale | 9,500 | $408k | 12.1% | Plan not stated | SEC |
| Jul 14, 2015 | Jul 15, 2015 | TETRAPHASE PHARMACEUTICALS INC | SVP and CFO | Form 4 sale | 7,500 | $367k | 9.8% | Plan not stated | SEC |
| Jun 15, 2015 | Jun 16, 2015 | TETRAPHASE PHARMACEUTICALS INC | SVP and CFO | Form 4 sale | 17,500 | $725k | 20.2% | Plan not stated | SEC |
| May 14, 2015 | May 18, 2015 | TETRAPHASE PHARMACEUTICALS INC | SVP and CFO | Form 4 sale | 15,000 | $589k | 15.9% | Plan not stated | SEC |
| Jun 17, 2014 | Jun 18, 2014 | TETRAPHASE PHARMACEUTICALS INC | SVP and CFO | Form 4 sale | 13,530 | $169k | 14.7% | Unusual | SEC |
| Mar 6, 2014 | Mar 10, 2014 | TETRAPHASE PHARMACEUTICALS INC | SVP and CFO | Form 4 sale | 4,510 | $62k | 4.7% | Plan not stated | SEC |
| Feb 12, 2014 | Feb 13, 2014 | TETRAPHASE PHARMACEUTICALS INC | SVP and CFO | Form 4 sale | 4,506 | $63k | 4.5% | Plan not stated | SEC |
| Feb 7, 2014 | Feb 11, 2014 | TETRAPHASE PHARMACEUTICALS INC | SVP and CFO | Form 4 sale | 9,928 | $141k | 8.9% | Plan not stated | SEC |